CY1118253T1 - Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους - Google Patents

Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους

Info

Publication number
CY1118253T1
CY1118253T1 CY20161101189T CY161101189T CY1118253T1 CY 1118253 T1 CY1118253 T1 CY 1118253T1 CY 20161101189 T CY20161101189 T CY 20161101189T CY 161101189 T CY161101189 T CY 161101189T CY 1118253 T1 CY1118253 T1 CY 1118253T1
Authority
CY
Cyprus
Prior art keywords
calibration material
immune determination
immune
determination
calibration
Prior art date
Application number
CY20161101189T
Other languages
English (en)
Inventor
John Forsyth Russell Robertson
Andrea Murray
Caroline Chapman
Anthony Barnes
Original Assignee
Oncimmune Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Limited filed Critical Oncimmune Limited
Publication of CY1118253T1 publication Critical patent/CY1118253T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

Χρήση ενός υλικού βαθμονόμησης, το οποίο περιλαμβάνει σωματικό υγρό θηλαστικών, για τη βαθμονόμηση ενός ανοσοπροσδιορισμού για την ανίχνευση των αυτοαντισωμάτων.
CY20161101189T 2007-12-24 2016-11-17 Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους CY1118253T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0725239.8A GB0725239D0 (en) 2007-12-24 2007-12-24 Calibrator for autoantibody assay
US1668907P 2007-12-26 2007-12-26
PCT/GB2008/004260 WO2009081165A1 (en) 2007-12-24 2008-12-23 Calibrator for immunoassays

Publications (1)

Publication Number Publication Date
CY1118253T1 true CY1118253T1 (el) 2017-06-28

Family

ID=39092384

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161101189T CY1118253T1 (el) 2007-12-24 2016-11-17 Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους

Country Status (18)

Country Link
US (3) US20090176319A1 (el)
EP (1) EP2223114B1 (el)
JP (1) JP5594776B2 (el)
CN (1) CN101952723B (el)
AU (1) AU2008339624B2 (el)
BR (1) BRPI0821397B1 (el)
CA (1) CA2707025C (el)
CY (1) CY1118253T1 (el)
DK (1) DK2223114T3 (el)
ES (1) ES2588731T3 (el)
GB (1) GB0725239D0 (el)
HK (1) HK1152380A1 (el)
HR (1) HRP20161109T1 (el)
IL (1) IL205733A (el)
PT (1) PT2223114T (el)
SG (1) SG186684A1 (el)
SI (1) SI2223114T1 (el)
WO (1) WO2009081165A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
GB2424273B (en) * 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
RU2636532C2 (ru) 2005-05-27 2017-11-23 Онкиммьюн Лимитед Улучшенные способы иммуноанализа
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
WO2007136025A1 (ja) * 2006-05-19 2007-11-29 Bml, Inc. 感染症の検出方法
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
EP3450979A3 (en) 2010-03-17 2019-04-24 The Regents of The University of Michigan Using phage epitopes to profile the immune response
KR102342988B1 (ko) * 2017-06-15 2021-12-27 션전 피알에스 리미티드 Ihc 항원 영상 척도 외삽 방법
US11662564B2 (en) 2017-06-15 2023-05-30 Shenzhen Prs Limited Paraffin shield coating for microscope slide
BR102021003012A2 (pt) 2020-02-19 2021-11-30 Univ Berlin Charite Métodos para o diagnóstico de infecção por sars-cov-2, kit e usos

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241044A (en) * 1978-12-28 1980-12-23 Abbott Laboratories Method of diagnosing cancer by detecting elevated anti-T antibody activity
JPS60192263A (ja) * 1984-03-13 1985-09-30 Teijin Ltd 免疫複合体測定用標準物質及びそれを用いた免疫複合体の測定法
NZ211453A (en) * 1984-03-22 1989-01-06 Biotechnology Research Enterpr Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides
US4937185A (en) * 1987-07-31 1990-06-26 The Ohio State University Research Foundation Detection of circulating antibodies to a cancer marker protein
US7282345B1 (en) * 1989-08-04 2007-10-16 Schering Ag C-erbB-2 external domain: GP75
US5110911A (en) * 1989-11-02 1992-05-05 Biomira, Inc. Human tumor-associated thomsen-friedenreich antigen
US5157020A (en) * 1990-05-24 1992-10-20 Research Corporation Tech., Inc. Synthetic senescent cell antigen
DE4120412C1 (el) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De
JPH067191A (ja) * 1991-09-26 1994-01-18 Konica Corp モノクローナル抗体、それを産生するハイブリド−マ、その対応抗原及びそれを用いた測定方法
US6322989B1 (en) * 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US6280962B1 (en) * 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
PT1024191E (pt) * 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
AU3603893A (en) * 1992-02-12 1993-09-03 Robert Perper Autoantibody assay and usage in the control of human disease
WO1993021529A1 (en) * 1992-04-14 1993-10-28 Duke University Method of detecting tumors containing complexes of p53 and hsp70
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5763164A (en) * 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
US5747268A (en) * 1993-04-22 1998-05-05 Dade International Inc. Tumor marker control
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5721105A (en) * 1994-02-20 1998-02-24 B.R.A.H.M.S. Diagnostica Gmbh Method for the immunological determination of proteins and kit for carrying out the method
US5789655A (en) * 1994-05-13 1998-08-04 The Regents Of The University Of California Transgenic animals expressing artificial epitope-tagged proteins
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
US5723343A (en) * 1995-08-28 1998-03-03 University Of Florida Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
JP3472048B2 (ja) * 1995-10-09 2003-12-02 鐘淵化学工業株式会社 自己免疫疾患の診断薬
JP2001517206A (ja) * 1996-08-16 2001-10-02 ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法
US6306636B1 (en) * 1997-09-19 2001-10-23 Arch Development Corporation Nucleic acid segments encoding wheat acetyl-CoA carboxylase
DE19805815C1 (de) * 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
US6388062B1 (en) * 1998-05-08 2002-05-14 The Wistar Institute Of Anatomy And Biology Modified p53 tetramerization domains having hydrophobic amino acid substitutions
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
JP3268494B2 (ja) * 1998-10-01 2002-03-25 俊成 広畑 全身性エリテマトーデス病態診断剤
US6387639B1 (en) * 1998-11-10 2002-05-14 Sloan-Kettering Institute For Cancer Research Ma family polypeptides and anti-Ma antibodies
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US7807810B2 (en) * 1999-04-08 2010-10-05 The Ohio State University Research Foundation Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
DE19939575C1 (de) * 1999-08-20 2001-08-02 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von Sjögren-Syndrom
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US6667160B2 (en) * 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
AU4465001A (en) * 2000-03-30 2001-10-15 Nippon Kayaku Kabushiki Kaisha Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
US20030138860A1 (en) * 2000-06-14 2003-07-24 Robertson John Forsyth Russell Cancer detection methods and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
US7745141B2 (en) * 2001-06-21 2010-06-29 New York University Mycobacterial proteins as early antigens for serodiagnosis and vaccines
US20030049692A1 (en) * 2002-09-16 2003-03-13 Norman Latov Detection of anti-glycolipid antibodies by latex agglutination assay
GB2424273B (en) * 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
WO2004063226A2 (en) * 2002-12-27 2004-07-29 Applied Research Systems Ars Holding N.V. Novel fibrillin-like polypeptides
JP2005352771A (ja) * 2004-06-10 2005-12-22 Hitachi Software Eng Co Ltd 発現プロファイルによるパターン認識システム
US20060141547A1 (en) * 2004-11-16 2006-06-29 Das Hasi R Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
EP1789435B1 (en) * 2005-09-12 2010-02-24 Industry Foundation of Chonnam National University A method for production of mature natural killer cell
TWI304443B (en) * 2005-12-30 2008-12-21 Nat Health Research Institutes Alpha-enolase specific antibody and method of use
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
AU2007297310B2 (en) * 2006-09-13 2013-11-07 Oncimmune Limited Improved immunoassay methods

Also Published As

Publication number Publication date
US20090176319A1 (en) 2009-07-09
US20210318320A1 (en) 2021-10-14
PT2223114T (pt) 2016-09-29
HK1152380A1 (zh) 2012-02-24
WO2009081165A1 (en) 2009-07-02
JP5594776B2 (ja) 2014-09-24
JP2011508197A (ja) 2011-03-10
SI2223114T1 (sl) 2016-11-30
GB0725239D0 (en) 2008-02-06
IL205733A0 (en) 2010-11-30
HRP20161109T1 (hr) 2016-11-04
AU2008339624B2 (en) 2014-11-20
CA2707025C (en) 2020-08-25
SG186684A1 (en) 2013-01-30
US20170074884A1 (en) 2017-03-16
BRPI0821397B1 (pt) 2018-10-09
AU2008339624A1 (en) 2009-07-02
EP2223114A1 (en) 2010-09-01
CA2707025A1 (en) 2009-07-02
EP2223114B1 (en) 2016-08-17
IL205733A (en) 2014-09-30
ES2588731T3 (es) 2016-11-04
CN101952723A (zh) 2011-01-19
CN101952723B (zh) 2016-05-11
BRPI0821397A2 (pt) 2017-05-23
DK2223114T3 (en) 2016-10-24

Similar Documents

Publication Publication Date Title
CY1118253T1 (el) Υλικο βαθμονομησης για ανοσοποσοτικους προσδιορισμους
EA201201101A1 (ru) Пассивный микрососуд и датчик
CY1121341T1 (el) Δοκιμες για την ανιχνευση της παρουσιας ή της ποσοτητας αντισωματος κατα αντισωματος φαρμακου
BR112015022763A8 (pt) sensor para detectar um analito
CY1119287T1 (el) Συζευγματα αντισωματων πυρρολοβενζοδιαζεπινης-αντι-her2
BR112014020542B8 (pt) Aparelho e método para determinar a pressão de saturação de um fluido
BR112013003633A2 (pt) técnicas de medição de toque capacitivo verdadeiro e força para sensores de toque capacitivo
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
CO6721041A2 (es) Anticuerpo anti-pcsk9 y métodos de uso
GB2538216A (en) Method of screening candidate biochemical entities targeting a target biochemical entity
CY1120164T1 (el) Ταψι ψησιματος
BR112012027816A2 (pt) marcadores preditivos úteis no tratamento da síndrome do x frágil (fxs).
BR112012002116A2 (pt) análise pvt de fluídos pressurizados.
CO6720984A2 (es) Anticuerpos anti-mesotelina e inmunoconjugados
BRPI0821137A2 (pt) Disposição de célula de medição de pressão de diafragma
DK2598021T3 (da) Analytsensorer med temperaturuafhængige membraner
WO2010020673A3 (de) Transkutane organfunktionsmessung
BR112018071384A2 (pt) método para detecção de uma posição de um dispositivo móvel de fundo do poço, e, conjunto de fundo do poço para detecção de uma posição de um dispositivo móvel.
MX336109B (es) Formacion de imagenes inmuno-tep de anticuerpos e inmunoconjugados y usos de lo mismo.
AR096017A1 (es) Sistema acústico y método de rastreo de una línea para el sistema de transferencia de fluidos
CY1123483T1 (el) Διαταξη δημιουργιας κρουστικων κυματων και μεθοδος απελευθερωσης ενος κρουστικου κυματος
IN2015DN01876A (el)
EP2550523A4 (en) Luminescence lifetime based analyte sensing instruments and calibration technique
TR201907065T4 (tr) Aptamer kullanarak hedef maddeyi tespit yöntemi.
DE602007003926D1 (de) Testen optisch verstärkter Verbindungen mit zeitlich gemultiplexten Testsignalen